Brief: Malin Corp Says Poseida Therapeutics Entered Into Broad Strategic Collaboration And License Agreement With Roche

Malin

04/08/2022 16:17

Aug 4 (Reuters) - Malin Corporation PLC  MLCM.I :
    * MALIN CORP- POSEIDA THERAPEUTICS ENTERED INTO BROAD
STRATEGIC
COLLABORATION AND LICENSE AGREEMENT WITH ROCHE
    * MALIN CORP- POSEIDA SAYS PRICING OF UNDERWRITTEN PUBLIC
OFFERING
OF 20MLN SHARES OF COMMON STOCK AT PRICE OF $3.5PER SHARE
    * MALIN CORP PLC  - POSEIDA ANNOUNCES PRICING OF PUBLIC
OFFERING
    * MALIN CORPORATION PLC - MALIN'S EQUITY STAKE IN POSEIDA
FOLLOWING COMPLETION OF OFFERING WILL BE APPROXIMATELY 14%

Further company coverage:  MLCM.I 

 ((Reuters.Briefs@thomsonreuters.com;))